Skip to main content
Book cover

Curious2018

Future Insights in Science and Technology

  • Book
  • © 2019

Overview

  • Presents the latest scientific and technological breakthroughs from innovation hotspots all over the world
  • Casts new light on the future of science and technology
  • Outlines the discussion held at the Curious2018 – Future Insight Conference, held on the occasion of the 350th anniversary of Merck, the world’s oldest pharmaceutical and chemical company
  • Shares a positive outlook on the future
  • Includes a foreword from J. Craig Venter

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (18 chapters)

  1. Creating a Better World with Science and Technology

  2. Science and Technology at Its Best—Examples from Curious2018 Future Insight Conference Keynote Speakers

  3. Bright Future

Keywords

About this book

This book expands the debate on the future of science and technology at the Curious2018 – Future Insight Conference, held on the occasion of Merck’s 350-year anniversary. In the respective chapters, some of the world’s top scientists, managers and entrepreneurs explore breakthrough technologies and how they can be applied to make a better world for humanity.

Divided into three parts, the book begins with an introduction to the vision of the conference and to the importance of curiosity for innovation, while also exploring the latest scientific developments that are shaping the future of healthcare, medicine, the life and material sciences, digitalization and new ways of working together. In the second part, particular attention is paid to new therapies and diagnostics; here, readers will learn how synthetic biology and chemistry are being used to solve problems that are essential to the future of humanity. The role of in-silico research is also discussed. In the final part ofthe book, readers will find some thoughts on ethical principles guiding our application of science and technology to create a bright future for humanity.

Given its interdisciplinary appeal, the book will inspire curiosity in a wide readership, from scholars and researchers to professionals with an interest in exploring the future of science and technology, solving the problems of today, and paving the way for a better tomorrow.

Chapters 1, 2, 3 and 17 are available open access under a Creative Commons Attribution-NonCommercial 4.0 International License via link.springer.com.

Editors and Affiliations

  • Vice President Innovation, Merck KGaA, Darmstadt, Germany

    Ulrich A.K. Betz

About the editor

Dr. Ulrich A.K. Betz, Vice President of Innovation at Merck, is responsible for innovation management and strategic academic collaborations. He is an accomplished R&D manager with more than 20 years of experience in the pharmaceutical and chemical industry, including positions in the President’s Office at Merck Biopharma, and positions reporting directly to the Heads of Research and Development at Bayer and Merck. In his current role, for example, he designed and implemented the Merck Innovation Cup, the Curious2018 – Future Insight Conference, the Merck Future Insight Prize, the Darmstadt Science Declaration, the idea competition innospire and the BioMed X Outcubator.

Prior to joining Merck in 2005, he worked at Bayer AG for seven years, in various scientific and managerial positions in Pharma Research. Ulrich received his PhD in functional genomics and immunology from the University of Cologne, Germany, and his diploma in biochemistry and physiological chemistryfrom the University of Tübingen, Germany. He is a co-inventor of the marketed anti-viral drug Letermovir (Prevymis) and of Pritelivir (Phase II). Ulrich has won several innovation awards such as the German Industry Innovation Award (the world’s oldest innovation award), two International Business Awards (Stevie Gold Awards Executive of the Year – Pharmaceuticals and Innovator of the Year), a Stevie Gold Germany Award (R&D Manager of the Year Germany), Edison Award, the Bio IT World Best Practice Award, and the German Idea Award. Ulrich is the author or co-author of over 90 publications (e.g. in Cell, Nature Medicine, and Nature Biotechnology).

Bibliographic Information

Publish with us